ABO Diag Overview

  • Founded
  • 2008
  • Status
  • Acquired/​Merged
  • Employees
  • 2
  • Latest Deal Type
  • M&A

ABO Diag General Information


Provider of research and development facilities dedicated to blood transfusion and more widely to immuno-haematology. The company works to develop and market in vitro diagnostic reagents and healthcare facilities through medical devices dedicated to blood transfusion.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Parent Company
Primary Office
  • 12 allée Isaac Newton
  • 33650 Martillac
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ABO Diag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Mar-2014 000 Completed Generating Revenue
2. Early Stage VC 01-Apr-2012 000 000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view ABO Diag’s complete valuation and funding history, request access »

ABO Diag Executive Team (2)

Name Title Board Seat Contact Info
Bruno Morino President
You’re viewing 1 of 2 executive team members. Get the full list »

ABO Diag Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ABO Diag Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AQUITI Gestion Venture Capital Minority 000 0000 000000 0
Acceleration International Accelerator/Incubator 000 0000 000000 0
Succès Europe Venture Capital Minority 000 0000 000000 0
To view ABO Diag’s complete investors history, request access »